Answers are grounded in this paper and cite their sources.
Randomized trial compares mini PCNL and standard PCNL outcomes in 66 patients with renal stones, suggesting mini PCNL may reduce complications.
Introduction: Percutaneous nephrolithotomy (PCNL) is the preferred treatment for large renal calculi, with Standard PCNL (S-PCNL) offering high stone-free rates (SFR) but being associated with increased bleeding, longer hospital stays, and postoperative pain. Mini PCNL(M-PCNL) was developed as a minimally invasive alternative, reducing renal trauma while maintaining efficacy. This study aimed to compare the safety, efficacy, and outcomes of M-PCNL versus S-PCNL in the treatment of renal stones. Materials And Methods: This randomized controlled trial was conducted at KD Medical College and Research Centre, Mathura, over two years, including 66 patients with renal stones. Patients were randomly assigned to either the S-PCNL or M-PCNL group. Standard PCNL was performed using a 22–26 Fr tract, while Mini PCNL used a 15.5–16.5 Fr tract. Postoperative outcomes, including stone clearance, operative time, complications, hospital stay, and pain scores, were analyzed. Results: Both techniques achieved comparable SFRs (96.97%). However, M-PCNL demonstrated advantages, including shorter hospital stays, reduced pain, lower analgesic requirements, and fewer complications. M-PCNLhad a longer operative time but resulted in less blood loss and a higher rate of tubeless procedures. Conclusion: Mini PCNL is a safe and effective alternative to Standard PCNL, offering similar efficacy with reduced morbidity. Despite a longer operative time, its benefits in terms of recovery and complications make it a preferable choice for selected patients. Further studies are needed to assess long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Dilshek Salmani (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: